Hu Q R, Li J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Sep;32(17):1363-1366. doi: 10.13201/j.issn.1001-1781.2018.17.018.
Local allergic rhinitis(local allergic rhinitis, LAR) is a newly proposed concept in recent years. It refers to patients with typical allergic rhinitis symptoms but skin prick test (SPT) and serum specificity IgE are negative, while nasal mucosa can produce local specific IgE and allergen provocation test (NAPT) are positive. The rate of clinical misdiagnose is high. The diagnosis mainly relies on typical nasal symptoms, positive NAPT and/or detection of local specific IgE. It needs to be distinguished from allergic rhinitis(AR) and non-allergic rhinitis (NAR). The main mechanism of its onset is the Th2-type allergic inflammatory response mediated by locally produced IgE. Eosinophils and mast cells are also involved in the inflammatory process. The current study considers LAR to be a separate disease from AR. Allergen immunotherapy(AIT) can be used to treat the disease..
局部变应性鼻炎(局部变应性鼻炎,LAR)是近年来新提出的概念。它指的是具有典型变应性鼻炎症状但皮肤点刺试验(SPT)和血清特异性IgE为阴性,而鼻黏膜可产生局部特异性IgE且变应原激发试验(NAPT)为阳性的患者。临床误诊率较高。诊断主要依靠典型的鼻部症状、NAPT阳性和/或局部特异性IgE的检测。它需要与变应性鼻炎(AR)和非变应性鼻炎(NAR)相鉴别。其发病主要机制是由局部产生的IgE介导的Th2型变应性炎症反应。嗜酸性粒细胞和肥大细胞也参与炎症过程。目前研究认为LAR是一种与AR不同的疾病。变应原免疫疗法(AIT)可用于治疗该疾病。